{"transactions":[{"id":4624133,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":37500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624132,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":3039,"price":98.995,"value":300845.805,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.60 to $99.305 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 115,476 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 280,228 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":115476,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624131,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":4141,"price":98.27,"value":406936.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.565 to $98.535 per share, inclusive."}],"balance_after":118515,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624130,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1525,"price":96.9009,"value":147773.8725,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.445 to $97.40 per share, inclusive."}],"balance_after":122656,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624129,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":148,"price":95.405,"value":14119.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.29 to $95.52 per share, inclusive."}],"balance_after":124181,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624128,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"sale","planned":false,"acquired":false,"shares":1648,"price":94.258,"value":155337.184,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $94.23 to $94.855 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4."}],"balance_after":124329,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4624127,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-18T20:43:16.000Z","date":"2026-09-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":125977,"source":{"system":"sec-edgar","filing":"0001689575-26-000032","document":"form4-09182026_080912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000032/form4-09182026_080912.xml","form_type":"4"}},{"id":4615857,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-09-11T20:13:35.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":false,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":6547,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6547},"source":{"system":"sec-edgar","filing":"0001689575-26-000030","document":"form4-09112026_080931.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000030/form4-09112026_080931.xml","form_type":"4"}},{"id":4615856,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:13:35.000Z","date":"2026-09-09","kind":"sale","planned":false,"acquired":false,"shares":3692,"price":84.2178,"value":310932.1176,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $84.07 to $84.22 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 107,227 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate of 298,978 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":107227,"source":{"system":"sec-edgar","filing":"0001689575-26-000030","document":"form4-09112026_080931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000030/form4-09112026_080931.xml","form_type":"4"}},{"id":4615855,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-09-11T20:13:35.000Z","date":"2026-09-09","kind":"exercise","planned":false,"acquired":true,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":110919,"source":{"system":"sec-edgar","filing":"0001689575-26-000030","document":"form4-09112026_080931.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000030/form4-09112026_080931.xml","form_type":"4"}},{"id":732197,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":56250,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732196,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":2429,"price":61.5035,"value":149392.0015,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.44 to $61.69 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 104,372 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 305,525 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":104372,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732195,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":5932,"price":60.8291,"value":360838.2212,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.40 to $61.35 per share, inclusive."}],"balance_after":106801,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732194,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"sale","planned":false,"acquired":false,"shares":2140,"price":59.7543,"value":127874.202,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.26 to $60.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":112733,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":732193,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-18T20:09:02.000Z","date":"2026-06-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":114873,"source":{"system":"sec-edgar","filing":"0001689575-26-000028","document":"form4-06182026_080658.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000028/form4-06182026_080658.xml","form_type":"4"}},{"id":741809,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-06-11T20:11:13.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":13094,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001689575-26-000026","document":"form4-06112026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000026/form4-06112026_080609.xml","form_type":"4"}},{"id":741808,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:11:13.000Z","date":"2026-06-09","kind":"sale","planned":false,"acquired":false,"shares":3639,"price":53.77,"value":195669.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 96,123 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 324,275 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":96123,"source":{"system":"sec-edgar","filing":"0001689575-26-000026","document":"form4-06112026_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000026/form4-06112026_080609.xml","form_type":"4"}},{"id":741807,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-11T20:11:13.000Z","date":"2026-06-09","kind":"exercise","planned":false,"acquired":true,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":99762,"source":{"system":"sec-edgar","filing":"0001689575-26-000026","document":"form4-06112026_080609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000026/form4-06112026_080609.xml","form_type":"4"}},{"id":795793,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche vesting on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":795792,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":18,"price":64.12,"value":1154.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 93,216 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 330,821 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":93216,"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":795791,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"sale","planned":false,"acquired":false,"shares":2154,"price":65.2,"value":140440.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":93234,"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":795790,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-05-01T20:28:12.000Z","date":"2026-04-29","kind":"exercise","planned":false,"acquired":true,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":95388,"source":{"system":"sec-edgar","filing":"0001689575-26-000024","document":"form4-05012026_080508.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000024/form4-05012026_080508.xml","form_type":"4"}},{"id":825317,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-30T21:30:12.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":false,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"25% of the total award vested or vests annually, with the first tranche vested on March 26, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":160000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001689575-26-000021","document":"form4-03302026_080325.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000021/form4-03302026_080325.xml","form_type":"4"}},{"id":825316,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:30:12.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":9883,"price":65.2143,"value":644512.9269,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.61 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 91,514 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 334,695 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":91514,"source":{"system":"sec-edgar","filing":"0001689575-26-000021","document":"form4-03302026_080325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000021/form4-03302026_080325.xml","form_type":"4"}},{"id":825315,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:30:12.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":5292,"price":64.5993,"value":341859.4956,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.99 to $64.96 per share, inclusive."}],"balance_after":101397,"source":{"system":"sec-edgar","filing":"0001689575-26-000021","document":"form4-03302026_080325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000021/form4-03302026_080325.xml","form_type":"4"}},{"id":825314,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:30:12.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":13412,"price":63.2791,"value":848699.2892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.96 to $63.955 per share, inclusive."}],"balance_after":106689,"source":{"system":"sec-edgar","filing":"0001689575-26-000021","document":"form4-03302026_080325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000021/form4-03302026_080325.xml","form_type":"4"}},{"id":825313,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:30:12.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":5117,"price":62.3319,"value":318952.3323,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.93 to $62.91 per share, inclusive."}],"balance_after":120101,"source":{"system":"sec-edgar","filing":"0001689575-26-000021","document":"form4-03302026_080325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000021/form4-03302026_080325.xml","form_type":"4"}},{"id":825312,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:30:12.000Z","date":"2026-03-26","kind":"sale","planned":false,"acquired":false,"shares":13229,"price":61.2909,"value":810817.3161,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.93 to $61.91 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 7 of this Form 4."}],"balance_after":125218,"source":{"system":"sec-edgar","filing":"0001689575-26-000021","document":"form4-03302026_080325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000021/form4-03302026_080325.xml","form_type":"4"}},{"id":825311,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-30T21:30:12.000Z","date":"2026-03-26","kind":"exercise","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":138447,"source":{"system":"sec-edgar","filing":"0001689575-26-000021","document":"form4-03302026_080325.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000021/form4-03302026_080325.xml","form_type":"4"}},{"id":838173,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T22:40:58.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"6.25% of the total award vested or vests quarterly, with the first tranche vested on June 16, 2023, subject to the Reporting Person's continued service to the Issuer on each vesting date. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":75000,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001689575-26-000019","document":"form4-03172026_100354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000019/form4-03172026_100354.xml","form_type":"4"}},{"id":838172,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-17T22:40:58.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":11921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"25% of the award vested or vests annually on the anniversary of the grant date, with the first tranche vested on March 15, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"25% of the award vested or vests annually on the anniversary of the grant date, with the first tranche vested on March 15, 2026, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":35763,"derivative":{"underlying":"Class A Common Stock","underlying_shares":11921},"source":{"system":"sec-edgar","filing":"0001689575-26-000019","document":"form4-03172026_100354.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000019/form4-03172026_100354.xml","form_type":"4"}},{"id":838171,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:40:58.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":772,"price":77.9354,"value":60166.1288,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.75 to $78.16 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 58,447 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person held RSUs representing contingent rights to receive up to an aggregate 414,695 shares of the Issuer's Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":58447,"source":{"system":"sec-edgar","filing":"0001689575-26-000019","document":"form4-03172026_100354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000019/form4-03172026_100354.xml","form_type":"4"}},{"id":838170,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:40:58.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":9229,"price":77.0495,"value":711089.8355,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.74 to $77.71 per share, inclusive."}],"balance_after":59219,"source":{"system":"sec-edgar","filing":"0001689575-26-000019","document":"form4-03172026_100354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000019/form4-03172026_100354.xml","form_type":"4"}},{"id":838169,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:40:58.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":7178,"price":76.3492,"value":548034.5576,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.735 to $76.73 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":68448,"source":{"system":"sec-edgar","filing":"0001689575-26-000019","document":"form4-03172026_100354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000019/form4-03172026_100354.xml","form_type":"4"}},{"id":838168,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:40:58.000Z","date":"2026-03-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":75626,"source":{"system":"sec-edgar","filing":"0001689575-26-000019","document":"form4-03172026_100354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000019/form4-03172026_100354.xml","form_type":"4"}},{"id":838167,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-17T22:40:58.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":11921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":56876,"source":{"system":"sec-edgar","filing":"0001689575-26-000019","document":"form4-03172026_100354.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000019/form4-03172026_100354.xml","form_type":"4"}},{"id":848806,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-11T20:26:37.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":19640,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001689575-26-000015","document":"form4-03112026_080333.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000015/form4-03112026_080333.xml","form_type":"4"}},{"id":848805,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-11T20:26:37.000Z","date":"2026-03-09","kind":"sale","planned":false,"acquired":false,"shares":3678,"price":86.748,"value":319059.144,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.5585 to $86.75 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 44,955 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 445,366 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":44955,"source":{"system":"sec-edgar","filing":"0001689575-26-000015","document":"form4-03112026_080333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000015/form4-03112026_080333.xml","form_type":"4"}},{"id":848804,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-11T20:26:37.000Z","date":"2026-03-09","kind":"exercise","planned":false,"acquired":true,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":48633,"source":{"system":"sec-edgar","filing":"0001689575-26-000015","document":"form4-03112026_080333.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000015/form4-03112026_080333.xml","form_type":"4"}},{"id":853659,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-09T11:54:54.000Z","date":"2026-03-06","kind":"grant","planned":false,"acquired":true,"shares":3404,"price":88.11,"value":299926.44,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Pursuant to a Subscription Agreement executed on March 6, 2026 between GeneDx Holdings Corp. (the \"Issuer\") and the reporting person, the reporting person acquired 3,404 shares of the Issuer's Class A common stock directly from the Issuer in an exempt transaction pursuant to Rule 16b-3(d) at a purchase price of $88.11 per share, the closing price of the Issuer's Class A common stock on March 6, 2026."}],"balance_after":42087,"source":{"system":"sec-edgar","filing":"0001689575-26-000013","document":"form4-03092026_110351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000013/form4-03092026_110351.xml","form_type":"4"}},{"id":858750,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-03-05T22:46:26.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":40418,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Each restricted stock unit (\"RSU\") reflected in this row represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration, subject to continued service as described in footnote 8 below."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"25% of the award shall vest annually on the anniversary of the grant date, with the first tranche vesting on April 1, 2027, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"25% of the award shall vest annually on the anniversary of the grant date, with the first tranche vesting on April 1, 2027, subject to the Reporting Person's continued service to the Issuer on each vesting date.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":40418,"derivative":{"underlying":"Class A Common Stock","underlying_shares":40418},"source":{"system":"sec-edgar","filing":"0001689575-26-000010","document":"form4-03052026_100322.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000010/form4-03052026_100322.xml","form_type":"4"}},{"id":858749,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:46:26.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":9133,"price":79.2492,"value":723782.9436,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of the 2025 PRSU Award. The sales were effected to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $79.00 to $79.64 per share, inclusive."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F6","text":"Following the reported sale undertaken to satisfy tax withholding liabilities and as of the date of filing of this Form 4, in addition to the 38,683 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate 451,912 shares of Class A Common Stock and options to purchase up to an aggregate 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":38683,"source":{"system":"sec-edgar","filing":"0001689575-26-000010","document":"form4-03052026_100322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000010/form4-03052026_100322.xml","form_type":"4"}},{"id":858748,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:46:26.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":10465,"price":78.6069,"value":822621.2085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of the 2025 PRSU Award. The sales were effected to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.00 to $78.93 per share, inclusive."}],"balance_after":47816,"source":{"system":"sec-edgar","filing":"0001689575-26-000010","document":"form4-03052026_100322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000010/form4-03052026_100322.xml","form_type":"4"}},{"id":858747,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:46:26.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":5861,"price":77.6261,"value":454966.5721,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of the 2025 PRSU Award. The sales were effected to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.00 to $77.92 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 and 5 of this Form 4."}],"balance_after":58281,"source":{"system":"sec-edgar","filing":"0001689575-26-000010","document":"form4-03052026_100322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000010/form4-03052026_100322.xml","form_type":"4"}},{"id":858746,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-03-05T22:46:26.000Z","date":"2026-03-03","kind":"grant","planned":false,"acquired":true,"shares":47684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents the certification of achievement of a performance-based restricted stock unit award granted to the Reporting Person by the Issuer's compensation committee on March 15, 2025 (the \"2025 PRSU Award\"). Vesting of the 2025 PRSU Award is based on achievement of corporate performance metrics tied to revenue and adjusted net income, and subject to the Reporting Person's continued service through the certification date of achievement thereof."}],"balance_after":64142,"source":{"system":"sec-edgar","filing":"0001689575-26-000010","document":"form4-03052026_100322.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000010/form4-03052026_100322.xml","form_type":"4"}},{"id":925396,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2026-02-02T21:30:35.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":3874,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001689575-26-000007","document":"form4-02022026_090231.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000007/form4-02022026_090231.xml","form_type":"4"}},{"id":925395,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:30:35.000Z","date":"2026-01-29","kind":"sale","planned":false,"acquired":false,"shares":1653,"price":93.9957,"value":155374.8921,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.53 to $94.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 16,458 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 411,494 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":16458,"source":{"system":"sec-edgar","filing":"0001689575-26-000007","document":"form4-02022026_090231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000007/form4-02022026_090231.xml","form_type":"4"}},{"id":925394,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-02-02T21:30:35.000Z","date":"2026-01-29","kind":"exercise","planned":false,"acquired":true,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":18111,"source":{"system":"sec-edgar","filing":"0001689575-26-000007","document":"form4-02022026_090231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957526000007/form4-02022026_090231.xml","form_type":"4"}},{"id":963228,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F13","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 16, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F13","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 16, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":93750,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963227,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":356,"price":140.95,"value":50178.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F12","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 14,237 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 415,368 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":14237,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963226,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":74,"price":150.75,"value":11155.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":14593,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963225,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":274,"price":149.198,"value":40880.252,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.01 to $149.32, inclusive."}],"balance_after":14667,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963224,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":932,"price":148.5496,"value":138448.2272,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.85 to $148.76, inclusive."}],"balance_after":14941,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963223,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":1970,"price":146.9282,"value":289448.554,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.605 to $147.51, inclusive."}],"balance_after":15873,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963222,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":1628,"price":145.3562,"value":236639.8936,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.80 to $145.55, inclusive."}],"balance_after":17843,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963221,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":940,"price":144.2738,"value":135617.372,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.75 to $144.74, inclusive."}],"balance_after":19471,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963220,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":604,"price":142.1187,"value":85839.6948,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.76 to $142.41, inclusive."}],"balance_after":20411,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963219,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":2679,"price":141.2047,"value":378287.3913,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.72 to $141.68, inclusive."}],"balance_after":21015,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963218,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":1031,"price":140.0824,"value":144424.9544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.70 to $140.465, inclusive."}],"balance_after":23694,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963217,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"sale","planned":false,"acquired":false,"shares":369,"price":138.93,"value":51265.17,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.65 to $139.41, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 4 through 11."}],"balance_after":24725,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":963216,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-18T22:18:54.000Z","date":"2025-12-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":25094,"source":{"system":"sec-edgar","filing":"0001689575-25-000017","document":"form4-12182025_101249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000017/form4-12182025_101249.xml","form_type":"4"}},{"id":972737,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-12-11T21:29:14.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":false,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% of the total award vested or vests quarterly, subject to the Reporting Person's continued service to the Issuer on each vesting date, and with the first tranche vested on March 9, 2023. These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":26186,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6547},"source":{"system":"sec-edgar","filing":"0001689575-25-000015","document":"form4-12112025_091209.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000015/form4-12112025_091209.xml","form_type":"4"}},{"id":972736,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-11T21:29:14.000Z","date":"2025-12-09","kind":"sale","planned":false,"acquired":false,"shares":3639,"price":159.28,"value":579619.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 6,344 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 434,118 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":6344,"source":{"system":"sec-edgar","filing":"0001689575-25-000015","document":"form4-12112025_091209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000015/form4-12112025_091209.xml","form_type":"4"}},{"id":972735,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-11T21:29:14.000Z","date":"2025-12-09","kind":"exercise","planned":false,"acquired":true,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":9983,"source":{"system":"sec-edgar","filing":"0001689575-25-000015","document":"form4-12112025_091209.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000015/form4-12112025_091209.xml","form_type":"4"}},{"id":1010701,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-10-31T20:42:02.000Z","date":"2025-10-29","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the total award vested on each of April 29, 2023 and April 29, 2024, and an additional 6.25% of the total award vested or vests thereafter on each quarterly anniversary, subject to the Reporting Person's continued service to the Issuer on each vesting date, with the last tranche scheduled to vest on April 29, 2026.  These RSUs do not have an expiration date; they either vest or are cancelled prior to the vesting date."}],"balance_after":7748,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001689575-25-000013","document":"form4-10312025_081058.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000013/form4-10312025_081058.xml","form_type":"4"}},{"id":1010700,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-31T20:42:02.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":4,"price":136.75,"value":547.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sale undertaken to satisfy tax withholding liabilities, in addition to the 3,436 shares of Class A Common Stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned RSUs representing contingent rights to receive up to an aggregate of 440,665 shares of Class A Common Stock and options to purchase up to an aggregate of 107,610 shares of Class A Common Stock, which RSUs and options vest according to their respective terms."}],"balance_after":3436,"source":{"system":"sec-edgar","filing":"0001689575-25-000013","document":"form4-10312025_081058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000013/form4-10312025_081058.xml","form_type":"4"}},{"id":1010699,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-31T20:42:02.000Z","date":"2025-10-29","kind":"sale","planned":false,"acquired":false,"shares":2154,"price":136.54,"value":294107.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":3440,"source":{"system":"sec-edgar","filing":"0001689575-25-000013","document":"form4-10312025_081058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000013/form4-10312025_081058.xml","form_type":"4"}},{"id":1010698,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-31T20:42:02.000Z","date":"2025-10-29","kind":"exercise","planned":false,"acquired":true,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":5594,"source":{"system":"sec-edgar","filing":"0001689575-25-000013","document":"form4-10312025_081058.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000013/form4-10312025_081058.xml","form_type":"4"}},{"id":1029419,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":136,"price":113.68,"value":15460.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F8","text":"Following the reported sales effectuated pursuant to a 10b5-1 plan, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":1720,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1029418,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":645,"price":111.8358,"value":72134.091,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.50 to $112.04, inclusive."}],"balance_after":1856,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1029417,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":200,"price":110.23,"value":22046.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."}],"balance_after":2501,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1029416,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":554,"price":109.1292,"value":60457.5768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.3837, inclusive."}],"balance_after":2701,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1029415,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":5163,"price":108.5526,"value":560457.0738,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.00 to $108.99, inclusive."}],"balance_after":3255,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1029414,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":4462,"price":107.6109,"value":480159.8358,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.00 to $107.9955, inclusive."}],"balance_after":8418,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1029413,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":1092,"price":106.6909,"value":116506.4628,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.00 to $106.98, inclusive."}],"balance_after":12880,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1029412,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-01T20:21:01.000Z","date":"2025-09-30","kind":"sale","planned":true,"acquired":false,"shares":606,"price":105.0988,"value":63689.8728,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.98 to $105.558, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 7."}],"balance_after":13972,"source":{"system":"sec-edgar","filing":"0001689575-25-000010","document":"form4-10012025_081057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000010/form4-10012025_081057.xml","form_type":"4"}},{"id":1036396,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2025-09-18T22:04:34.000Z","date":"2025-09-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":112500,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001689575-25-000003","document":"form4-09182025_100930.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000003/form4-09182025_100930.xml","form_type":"4"}},{"id":1036395,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-18T22:04:34.000Z","date":"2025-09-16","kind":"sale","planned":false,"acquired":false,"shares":10501,"price":121.4727,"value":1275584.8227,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold as part of a block trade for multiple security holders of the Issuer in multiple transactions at prices ranging from $118.28 to $123.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 3 with regard to the block trade."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Following the reported sales, in addition to the 14,578 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 444,539 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":14578,"source":{"system":"sec-edgar","filing":"0001689575-25-000003","document":"form4-09182025_100930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000003/form4-09182025_100930.xml","form_type":"4"}},{"id":1036394,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF EXECUTIVE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-09-18T22:04:34.000Z","date":"2025-09-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":25079,"source":{"system":"sec-edgar","filing":"0001689575-25-000003","document":"form4-09182025_100930.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000168957525000003/form4-09182025_100930.xml","form_type":"4"}},{"id":1042951,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-09-11T20:07:22.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":false,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":32733,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6546},"source":{"system":"sec-edgar","filing":"0001415889-25-024271","document":"form4-09112025_080917.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925024271/form4-09112025_080917.xml","form_type":"4"}},{"id":1042950,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-11T20:07:22.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":18,"price":129.079,"value":2323.422,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sales, in addition to the 6,329 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 463,289 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":6329,"source":{"system":"sec-edgar","filing":"0001415889-25-024271","document":"form4-09112025_080917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925024271/form4-09112025_080917.xml","form_type":"4"}},{"id":1042949,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-11T20:07:22.000Z","date":"2025-09-09","kind":"sale","planned":false,"acquired":false,"shares":3639,"price":128.05,"value":465973.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":6347,"source":{"system":"sec-edgar","filing":"0001415889-25-024271","document":"form4-09112025_080917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925024271/form4-09112025_080917.xml","form_type":"4"}},{"id":1042948,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-09-11T20:07:22.000Z","date":"2025-09-09","kind":"exercise","planned":false,"acquired":true,"shares":6546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":9986,"source":{"system":"sec-edgar","filing":"0001415889-25-024271","document":"form4-09112025_080917.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925024271/form4-09112025_080917.xml","form_type":"4"}},{"id":1078439,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-07-31T20:04:37.000Z","date":"2025-07-29","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the underlying shares each vest on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"25% of the underlying shares each vest on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":11622,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001415889-25-020713","document":"form4-07312025_080732.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925020713/form4-07312025_080732.xml","form_type":"4"}},{"id":1078438,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-31T20:04:37.000Z","date":"2025-07-29","kind":"sale","planned":false,"acquired":false,"shares":2154,"price":105.31,"value":226837.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Following the reported sales, in addition to the 3,440 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of\n469,835 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":3440,"source":{"system":"sec-edgar","filing":"0001415889-25-020713","document":"form4-07312025_080732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925020713/form4-07312025_080732.xml","form_type":"4"}},{"id":1078437,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-31T20:04:37.000Z","date":"2025-07-29","kind":"exercise","planned":false,"acquired":true,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":5594,"source":{"system":"sec-edgar","filing":"0001415889-25-020713","document":"form4-07312025_080732.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925020713/form4-07312025_080732.xml","form_type":"4"}},{"id":1088635,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-11T20:03:21.000Z","date":"2025-07-09","kind":"sale","planned":true,"acquired":false,"shares":3220,"price":93,"value":299460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Following the reported sales, in addition to the 1,720 shares of Class A common stock beneficially owned by the Reporting Person, the Reporting Person beneficially owned restricted stock units (\"RSUs\") representing contingent rights to receive up to an aggregate of 473,709 shares of Class A common stock and options to purchase up to an aggregate of 107,610 shares of Class A common stock, which RSUs and options vest according to their respective terms."}],"balance_after":1720,"source":{"system":"sec-edgar","filing":"0001415889-25-019666","document":"form4-07112025_080717.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925019666/form4-07112025_080717.xml","form_type":"4"}},{"id":1092600,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-03T18:32:36.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":135,"price":92.4609,"value":12482.2215,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.3088 to $92.50 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4940,"source":{"system":"sec-edgar","filing":"0001415889-25-019275","document":"form4-07032025_060731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925019275/form4-07032025_060731.xml","form_type":"4"}},{"id":1092599,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-03T18:32:36.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":2594,"price":91.551,"value":237483.294,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.21 to $92.17 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5075,"source":{"system":"sec-edgar","filing":"0001415889-25-019275","document":"form4-07032025_060731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925019275/form4-07032025_060731.xml","form_type":"4"}},{"id":1092598,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-07-03T18:32:36.000Z","date":"2025-07-01","kind":"sale","planned":true,"acquired":false,"shares":6928,"price":90.6777,"value":628215.1056,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.21 to $91.20 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":7669,"source":{"system":"sec-edgar","filing":"0001415889-25-019275","document":"form4-07032025_060731.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925019275/form4-07032025_060731.xml","form_type":"4"}},{"id":1106414,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-06-18T20:14:42.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 16, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":131250,"derivative":{"underlying":"Class A Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001415889-25-017666","document":"form4-06182025_080637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925017666/form4-06182025_080637.xml","form_type":"4"}},{"id":1106413,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:14:42.000Z","date":"2025-06-16","kind":"sale","planned":false,"acquired":false,"shares":10501,"price":64.773,"value":680181.273,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":14597,"source":{"system":"sec-edgar","filing":"0001415889-25-017666","document":"form4-06182025_080637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925017666/form4-06182025_080637.xml","form_type":"4"}},{"id":1106412,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:14:42.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":25098,"source":{"system":"sec-edgar","filing":"0001415889-25-017666","document":"form4-06182025_080637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925017666/form4-06182025_080637.xml","form_type":"4"}},{"id":1115135,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-06-11T20:04:11.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":false,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"6.25% vest in quarterly installments over the 4-year period commencing on March 9, 2023 until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":39279,"derivative":{"underlying":"Class A Common Stock","underlying_shares":6547},"source":{"system":"sec-edgar","filing":"0001415889-25-016650","document":"form4-06112025_080607.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925016650/form4-06112025_080607.xml","form_type":"4"}},{"id":1115134,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-11T20:04:11.000Z","date":"2025-06-09","kind":"sale","planned":false,"acquired":false,"shares":3639,"price":72.55,"value":264009.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary transaction by the Reporting Person."}],"balance_after":6348,"source":{"system":"sec-edgar","filing":"0001415889-25-016650","document":"form4-06112025_080607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925016650/form4-06112025_080607.xml","form_type":"4"}},{"id":1115133,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-11T20:04:11.000Z","date":"2025-06-09","kind":"exercise","planned":false,"acquired":true,"shares":6547,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":9987,"source":{"system":"sec-edgar","filing":"0001415889-25-016650","document":"form4-06112025_080607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925016650/form4-06112025_080607.xml","form_type":"4"}},{"id":1162522,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Unit","published_at":"2025-05-01T23:44:43.000Z","date":"2025-04-29","kind":"exercise","planned":false,"acquired":false,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the underlying restricted stock units each vests on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"25% of the underlying restricted stock units each vests on April 29, 2023 and April 29, 2024, and 6.25% vest in quarterly installments thereafter until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date."}],"balance_after":15496,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3874},"source":{"system":"sec-edgar","filing":"0001415889-25-011695","document":"form4-05012025_110537.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925011695/form4-05012025_110537.xml","form_type":"4"}},{"id":1162521,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-01T23:44:43.000Z","date":"2025-04-29","kind":"sale","planned":false,"acquired":false,"shares":2154,"price":113.09,"value":243595.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported on this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sales were to satisfy tax withholding obligations to be funded by a \"sell to\ncover\" transaction"}],"balance_after":3440,"source":{"system":"sec-edgar","filing":"0001415889-25-011695","document":"form4-05012025_110537.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925011695/form4-05012025_110537.xml","form_type":"4"}},{"id":1162520,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-05-01T23:44:43.000Z","date":"2025-04-29","kind":"exercise","planned":false,"acquired":true,"shares":3874,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration."}],"balance_after":5594,"source":{"system":"sec-edgar","filing":"0001415889-25-011695","document":"form4-05012025_110537.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925011695/form4-05012025_110537.xml","form_type":"4"}},{"id":1174139,"issuer":{"id":1634,"kind":"organization","name":"GeneDx Holdings Corp.","symbol":"WGS"},"owners":[{"id":36831,"kind":"person","name":"Stueland Katherine","position":1,"cik":"0001689575","reported_name":"Stueland Katherine","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Class A Common Stock","published_at":"2025-04-10T20:11:47.000Z","date":"2025-04-09","kind":"sale","planned":true,"acquired":false,"shares":705,"price":97.2443,"value":68557.2315,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F17","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.9864 to $97.54 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":1720,"source":{"system":"sec-edgar","filing":"0001415889-25-010535","document":"form4-04102025_080442.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1818331/000141588925010535/form4-04102025_080442.xml","form_type":"4"}}],"next_cursor":"2025-04-10T20:11:47.000000Z,1174139"}